(Q44548259)

English

Quality of monitoring for metabolic effects associated with second generation antipsychotics in patients with schizophrenia on public insurance

scientific article published on 18 December 2010

In more languages
default for all languages
No label defined

No description defined

Statements

Quality of monitoring for metabolic effects associated with second generation antipsychotics in patients with schizophrenia on public insurance (English)

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit